Company / Return on Equity (ROE)
uniQure N.V. Return on Equity (ROE) History
FY2015-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-148.5%
FY2023
5-year range
-148.5% / 55.3%
FY2019-FY2023
Trend
-457.6%
vs FY2022
Sector context
#171 of 190
Health Care
What the data says
uniQure N.V. reports negative total equity of -148.5% in FY2023. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-148.5% in FY2023 with a 5-year CAGR of -102.2%.
Declined from 55.3% to -148.5% over the past 2 years.
Health Care sector context is included.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -97.3pp
- 5-Year Change
- -102.2pp
- 10-Year Change
- -
Sector benchmark
Bottom 10% in Health CareTop 90% of 190This company -148.5% Sector average -50.3%
▼
-195.2% below sector average
Key checks
Key Insights
- In FY2023, return on equity (roe) decreased 457.6% year-over-year.
- Currently 98.2pp below the Health Care sector average.
- Peak return on equity (roe) was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.58 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | -148.5% | -457.6% |
| FY2022 | -26.6% | -148.2% |
| FY2021 | 55.3% | +207.9% |
| FY2020 | -51.3% | -33.3% |
| FY2019 | -38.5% | +17.1% |
| FY2018 | -46.4% | +47.7% |
| FY2017 | -88.7% | +23.1% |
| FY2016 | -115.3% | -79.7% |
| FY2015 | -64.2% | - |
As of FY2023 · SEC Form 10-K · Last checked Jul 3, 2026